🔴 Indaptus Therapeutics is trading 8.25% down with no clear catalyst identified

Indaptus Therapeutics is trading 8.25% down at $1.95 on October 2, 2026, with no verified company-specific announcement explaining the move.

• Shares closed at $2.12 on October 1, down 7.83%, extending a steep multi-session slide after further losses in recent sessions.
• The previously announced private placement is not evidence of a new catalyst today. Supplied broader indices are up, and available information does not establish a clear cause.